FindTrial
Sign In

Effect of different concentrations of sevoflurane on deep neuromuscular blockade by continuous intravenous infusion of rocuronium in obese patients undergoing laparoscopic bariatric surgery

Effect of different concentrations of sevoflurane on deep neuromuscular blockade by continuous intravenous infusion of rocuronium in obese patients undergoing laparoscopic bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020583
Enrollment
Unknown
Registered
2019-01-09
Start date
2019-01-15
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic bariatric surgery

Interventions

Sevoflurane:sevoflurane
TIVA:Propofol

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists (ASA) physical status classifications I–II; 2. Ability to give informed consent; 3. male or female patients aged 18–65 years; 4. BMI > 30kg/m2.

Exclusion criteria

Exclusion criteria: 1. Allergy to the electrode; 2. History of neuromuscular, renal or hepatic disease; 3. Treatment with drugs known to affect neuromuscular function.

Design outcomes

Primary

MeasureTime frame
time from stopping the intravenous pumping of the muscle relaxant to the TOF value returns to 0.9;—

Countries

China

Contacts

Public ContactLiujiazi Shao

Beijing Friendship Hospital, Capital Medical University

shaoliujiazi@163.com+86 13426498734

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026